Company Filing History:
2 out of 219 
2 out of 86 
2 out of 80 
Years Active: 2011-2012
Title: Masamichi Yamada: Innovator in Fusion Protein Technology
Introduction
Masamichi Yamada is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents, Yamada's work focuses on enhancing the stability and transferability of therapeutic proteins.
Latest Patents
Yamada's latest patents involve the creation of proteins with an attached short peptide of acidic amino acids. These patents disclose a fusion protein comprising the enzyme N-acetylgalactosamine-6-sulfate sulfatase, along with a short peptide consisting of 4-15 acidic amino acids attached to the enzyme on its N-terminal side. The pharmaceutical composition containing this fusion protein is designed for the treatment of type A Morquio disease. Compared to the native enzyme protein, the fusion protein exhibits higher transferability to bone tissues and improved stability in the blood.
Career Highlights
Throughout his career, Masamichi Yamada has worked with prestigious institutions such as Saint Louis University and Kanazawa University. His research has significantly advanced the understanding of protein engineering and its applications in medicine.
Collaborations
Yamada has collaborated with notable colleagues, including Shunji Tomatsu and Ken'ichi Miyamoto. Their combined expertise has contributed to the successful development of innovative biotechnological solutions.
Conclusion
Masamichi Yamada's work in fusion protein technology represents a significant advancement in the treatment of genetic disorders. His innovative approach continues to inspire future research in the field of biotechnology.